Similar articles

• Chromosome aberrations and metronidazole.

  Mitelman F, Hartley-Asp B, Ursing B. Mitelman F, et al. Lancet. 1976 Oct 9;2(7989):802. doi: 10.1016/s0140-6736(76)90636-x. Lancet. 1976. PMID: 61473 No abstract available.
• Mechanisms involved in the formation of mutagen-induced chromosome aberrations as determined by premature chromosome condensation.

  Wolff S, Pantelias GE. Wolff S, et al. Prog Clin Biol Res. 1986;209B:167-74. Prog Clin Biol Res. 1986. PMID: 3749075 No abstract available.
• Metronidazole: absence of mammalian cytogenicity.

  Hartley-Asp B. Hartley-Asp B. Scand J Infect Dis Suppl. 1981;26:72-4. Scand J Infect Dis Suppl. 1981. PMID: 6941459
• Mutagenicity of metronidazole.

  Hartley-Asp B. Hartley-Asp B. Lancet. 1979 Feb 3;1(8110):275. doi: 10.1016/s0140-6736(79)90805-5. Lancet. 1979. PMID: 84931 No abstract available.
• Genotoxicity and carcinogenicity of metronidazole.

  Dobiás L, Cerná M, Rössner P, Srám R. Dobiás L, et al. Mutat Res. 1994 Jun;317(3):177-94. Mutat Res. 1994. PMID: 7515153 Review. No abstract available.